Roche buys Ventana in $3.4 billion deal

Share this article:
Roche said Tuesday it will pay $3.4 billion to purchase US-based drug testing instrument maker Ventana Medical Systems.

Ventana will keep its headquarters in Tucson, AZ, while its CEO Christopher Gleeson will join the board of Roche's diagnostics division, the companies said in a statement.

Wall Street analysts said the offer from Roche came as no surprise as the Swiss drugmaker has been trying to take over Ventana since June, and extended offers five times before clinching the deal.

Ventana currently employs 800 people and in 2006 had $238.2 million in sales of chemicals and instrument used to automatically prepare tissue samples for cancer screening and the testing of new drugs.
Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.